Free Trial

Abbott Laboratories (ABT) SEC Filings & 10K Form

$113.86
+0.76 (+0.67%)
(As of 09/6/2024 ET)

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
09/04/2024
7:03 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:52 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:02 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:39 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:35 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:59 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2024
3:02 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
5:05 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:11 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:16 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:22 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:29 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:54 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:00 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:43 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:48 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:33 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:38 PM
Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
5:50 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:58 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:32 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:40 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:09 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:14 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:18 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:22 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:56 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:00 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:05 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:39 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:44 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:50 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:53 PM
Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:39 PM
Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:45 PM
Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:22 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:25 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:32 PM
Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
NASDAQ to crash 50%? (Ad)

During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...

02/27/2024
5:13 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:45 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:35 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:38 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:40 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:43 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:27 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:29 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:33 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:23 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:03 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:15 PM
Abbott Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
4:30 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:04 PM
Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:38 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:28 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:30 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:33 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
4:36 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
5:45 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:46 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:48 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:49 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
4:35 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:ABT) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners